TrialsgrambetaRCTs are beautiful

2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

This guideline cites 18 of the 61 landmark trials in our Emergency medicine register.

Published on 22 October 2025 — the same day as the ERC Guidelines and drawing on the same ILCOR evidence evaluation — the 2025 AHA Guidelines for CPR and ECC are the first full rewrite since 2020, with roughly 760 recommendations across systems of care, adult, paediatric and neonatal life support, post-cardiac-arrest care, special circumstances, resuscitation education and ethics. Headline changes include a single unified Chain of Survival, new guidance on choking and on opioid-associated emergencies, and a restatement of post-arrest temperature control. This page groups the landmark trials from our register that sit behind those recommendations by theme.

Adult basic life support & defibrillation2

  • 2022DOSE-VF⁠ICU · Post-arrest · DefibrillationIn 405 patients with refractory ventricular fibrillation, double sequential external defibrillation improved survival to hospital discharge versus standard defibrillation.RR 2.2195% CI 1.33-3.67Read →
  • 2015PARAMEDIC (LUCAS-2)⁠Emergency · CPR · Mechanical CPRIn 4,471 out-of-hospital cardiac arrests, LUCAS-2 mechanical chest compression did not improve 30-day survival versus manual CPR, and worsened functional outcome at 3 months.OR 0.8695% CI 0.64-1.15Read →

Adult advanced life support: vasopressors & antiarrhythmics2

  • 2018PARAMEDIC2 Core⁠ICU · Post-arrest · AdrenalineIn 8,014 adults with OHCA, 1 mg intravenous adrenaline increased 30-day survival versus placebo, without improving favourable neurologic survival.OR 1.39Read →
  • 2016ALPS⁠Emergency · CPR · AntiarrhythmicsIn 3,026 adults with OHCA and shock-refractory VF/pVT, amiodarone or lidocaine did not improve survival to hospital discharge versus placebo.Read →

Airway management & oxygenation3

  • 2023DEVICE⁠Emergency · Airway · Video laryngoscopyIn 1,417 critically ill adults in EDs and ICUs, video laryngoscopy improved first-pass intubation success versus direct laryngoscopy.85.1% vs 70.8%Read →
  • 2019PreVent 2019⁠Emergency · Airway · Bag-mask ventilationIn 401 critically ill adults undergoing tracheal intubation, bag-mask ventilation between induction and laryngoscopy reduced severe hypoxaemia versus no ventilation.96% vs 93%Read →
  • 2018AIRWAYS-2⁠Emergency · Airway · Supraglottic vs ETIIn 9,296 adults with out-of-hospital cardiac arrest, an i-gel supraglottic airway did not change favourable neurologic outcome at discharge versus endotracheal intubation.6.4% vs 6.8%Read →

Extracorporeal CPR (ECPR)3

  • 2023INCEPTION⁠ICU · Post-arrest · ECPRIn 160 patients with refractory OHCA, ECPR did not improve 30-day survival with favourable neurology versus conventional CPR.OR 1.495% CI 0.5-3.5Read →
  • 2022PRAGUE-OHCA⁠Emergency · ECPR · ECPRIn 256 patients with refractory out-of-hospital cardiac arrest, a hyperinvasive strategy (intra-arrest transport + ECPR + immediate cath) did not significantly improve 180-day CPC 1–2 survival versus standard ACLS.OR 1.6395% CI 0.93-2.85Read →
  • 2020ARREST 2020⁠ICU · Post-arrest · ECPRIn 30 patients with refractory out-of-hospital VF arrest, ECPR plus expedited coronary angiography improved survival to hospital discharge versus standard ACLS.43% vs 7%Read →

Post-cardiac-arrest care: temperature control3

  • 2021TTM2 Core⁠Cardiology · Critical care · Temperature managementIn 1,861 unconscious adults after OHCA, hypothermia at 33 °C did not reduce all-cause mortality at 6 months compared with targeted normothermia (≤ 37.5 °C).RR 1.04Read →
  • 2019HYPERION⁠Cardiology · Critical care · Temperature managementIn 581 patients resuscitated from cardiac arrest with a non-shockable rhythm, targeted hypothermia at 33 °C improved favourable neurological outcome compared with targeted normothermia.10.2% vs 5.7%Read →
  • 2013TTM⁠Cardiology · Critical care · Temperature managementIn 939 unconscious survivors of out-of-hospital cardiac arrest, targeted temperature of 33 °C did not improve survival or neurological outcome compared with 36 °C.HR 1.06Read →

Post-cardiac-arrest care: blood-pressure & oxygen targets2

  • 2022BOX (BP)⁠ICU · Post-arrest · Haemodynamic targetsIn 789 comatose survivors of OHCA, a higher MAP target (77 mm Hg) did not change the composite of death or severe disability versus a lower target (63 mm Hg).HR 1.0895% CI 0.84-1.37Read →
  • 2022BOX (O₂)⁠ICU · Post-arrest · Oxygen targetsIn 789 comatose survivors of OHCA, restrictive oxygenation (PaO₂ 68–75 mm Hg) did not change the composite of death or severe disability compared with liberal (98–105 mm Hg).HR 0.95Read →

Coronary angiography & cardiogenic shock after arrest3

  • 2021TOMAHAWK⁠Emergency · Post-arrest · Immediate angiographyIn 554 OHCA patients without ST-elevation, immediate angiography did not improve 30-day all-cause mortality versus delayed/selective strategy.HR 1.2895% CI 1.00-1.63Read →
  • 2019COACT⁠Emergency · Post-arrest · Immediate angiographyIn 552 OHCA survivors with a shockable rhythm and no STEMI, immediate coronary angiography did not improve 90-day survival versus delayed angiography.OR 0.8995% CI 0.62-1.27Read →
  • 2017CULPRIT-SHOCK Core⁠ICU · CS / MCS · RevascularisationIn 706 patients with multivessel disease and cardiogenic shock, culprit-only PCI with staged completion reduced 30-day death or RRT compared with immediate multivessel PCI.RR 0.83Read →

Cited landmark trials not yet in the register6

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

  • 2018PART

    Laryngeal tube versus endotracheal intubation as the initial airway strategy during out-of-hospital CPR.

  • 2011ROC PRIMED

    Impedance-threshold device and analyse-early versus analyse-later CPR — neither improved survival.

  • 2023TAME

    Targeted mild hypercapnia versus normocapnia after out-of-hospital cardiac arrest — no neurological benefit.

  • 2021VAM-IHCA

    Vasopressin plus methylprednisolone during in-hospital cardiac arrest — more ROSC, no survival benefit.

  • 2025PARAMEDIC-3

    Intraosseous-first versus intravenous-first drug route in out-of-hospital cardiac arrest — no survival difference.

  • 2025IVIO

    Danish trial of intraosseous versus intravenous access in out-of-hospital cardiac arrest — no benefit on ROSC or survival.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.